journal
MENU ▼
Read by QxMD icon Read
search

Medical Clinics of North America

journal
https://read.qxmd.com/read/31078206/women-s-mental-health-progress-and-realities
#1
EDITORIAL
Susan G Kornstein, Anita H Clayton
No abstract text is available yet for this article.
July 2019: Medical Clinics of North America
https://read.qxmd.com/read/31078205/update-on-reproductive-rights-and-women-s-mental-health
#2
REVIEW
Nada Logan Stotland
Reproductive rights are essential to the recognition/treatment of women as full-fledged human beings/citizens. Barriers to reproductive rights pose a grave danger to women's well-being. This article explores the origins of these barriers, their nature, and their impact on mental health. The most controversial relationship is between induced abortion and mental health. Barriers, misinformation, and coercion affecting contraceptive, abortion, and pregnancy care are an ongoing danger to women's mental health and the well-being of their families...
July 2019: Medical Clinics of North America
https://read.qxmd.com/read/31078204/update-on-mental-health-aspects-of-intimate-partner-violence
#3
REVIEW
Donna Eileen Stewart, Simone Natalie Vigod
Intimate partner violence (IPV) is common worldwide and occurs in more than one-third of American women and psychiatric patients. As well as physical injuries, it may cause mental health sequelae, such as depression, anxiety, posttraumatic stress disorder, psychosis, inability to trust others, self-harm, and a host of psychosomatic conditions, that may be referred to psychiatrists. It is imperative that psychiatrists know the risk factors, how to assist disclosure of IPV, and how to safely respond. Psychiatrists must know the best evidence-based management of IPV and its mental health sequelae to best assist patients who have been exposed to IPV...
July 2019: Medical Clinics of North America
https://read.qxmd.com/read/31078203/mental-health-in-sexual-minority-and-transgender-women
#4
REVIEW
Julie K Schulman, Laura Erickson-Schroth
Although sexual minority women (SMW) and transgender women have become increasingly visible in recent years and have made progress in achieving civil rights, they continue to face significant levels of discrimination, stigma, and physical violence. As a result, each group faces a wide variety of health disparities, including mental illness and substance use disorders. Overall, both SMW and transgender women experience higher rates of mood and anxiety disorders, suicidality, and substance use disorders than their heterosexual and cisgender counterparts...
July 2019: Medical Clinics of North America
https://read.qxmd.com/read/31078202/dementia-in-women
#5
REVIEW
Todd M Derreberry, Suzanne Holroyd
Despite the progress made in the understanding of the etiology, neuropathophysiology, and treatment of different types of dementia, such disorders continue to pose huge health problems worldwide. The differential effect of the burden of disease on women is just being realized. These effects range from direct effects of the disease processes themselves, the way women experience the disease, and the caregiver burden. This article provides a brief overview of the available information on this topic.
July 2019: Medical Clinics of North America
https://read.qxmd.com/read/31078201/women-and-addiction-an-update
#6
REVIEW
Nassima Ait-Daoud, Derek Blevins, Surbhi Khanna, Sana Sharma, Christopher P Holstege, Pooja Amin
Gender-related alcohol and drug abuse problems are related not only to biological differences, but also to social and environmental factors, which can influence the clinical presentation, consequences of use, and treatment approaches. Women are becoming the fastest-growing population of substance abusers in the United States. Given that women experience a more rapid progression of their addiction than men, it is important that we understand and address the differences to help develop prevention and treatment programs that are tailored for women, incorporating trauma assessment and management, identification and intervention for medical and psychiatric comorbidities, financial independence, pregnancy, and child care...
July 2019: Medical Clinics of North America
https://read.qxmd.com/read/31078200/female-sexual-dysfunction
#7
REVIEW
Anita H Clayton, Elia Margarita Valladares Juarez
Female sexual dysfunction can drastically diminish quality of life for many women. It is estimated that in the United States 40% of women have sexual complaints. These conditions are frequently underdiagnosed and undertreated. Terminology and classification systems of female sexual dysfunction can be confusing and complicated, which hampers the process of clinical diagnosis, making accurate diagnosis difficult. There are few treatment options available for female sexual dysfunctions, however, some interventions may be of benefit and are described...
July 2019: Medical Clinics of North America
https://read.qxmd.com/read/31078199/update-on-binge-eating-disorder
#8
REVIEW
Anna I Guerdjikova, Nicole Mori, Leah S Casuto, Susan L McElroy
Binge eating disorder (BED) is the most common eating disorder and an important public health problem. Lifetime prevalence of BED in the United States is 2.6%. In contrast to other eating disorders, the female to male ratio in BED is more balanced. BED co-occurs with a plethora of psychiatric disorders, most commonly mood and anxiety disorders. BED is also associated with obesity and its numerous complications. Although BED is similar in men and women in presentation and treatment outcomes, there are some key neurobiological differences that should be taken in consideration when personalizing treatment...
July 2019: Medical Clinics of North America
https://read.qxmd.com/read/31078198/depression-and-menopause-an-update-on-current-knowledge-and-clinical-management-for-this-critical-window
#9
REVIEW
Claudio N Soares
Windows of vulnerability for depression have been associated with increased sensitivity to hormonal changes experienced by some women during the luteal phase, postpartum, and/or menopause. Increased awareness has resulted in greater adoption of screening tools for mood and behavioral changes and tailored therapies. This article discusses study results and controversies surrounding therapies uniquely designed for menopause-related depression.
July 2019: Medical Clinics of North America
https://read.qxmd.com/read/31078197/psychopharmacology-in-pregnancy-and-breastfeeding
#10
REVIEW
Jennifer L Payne
The use of psychotropic drugs during pregnancy and breastfeeding remains a controversial topic. There are several reasons for the controversy, ranging from the misperception that pregnancy is protective against mental illness, to the notion that women should be "pure" during pregnancy and avoid all extraneous substance use, and finally, to the stigma and misunderstanding of psychiatric illness and underestimation of how serious it can be. Fortunately, the currently available data are reassuring for most psychiatric medications-properly controlled studies indicate little to no risk for most (but not all) psychiatric medications...
July 2019: Medical Clinics of North America
https://read.qxmd.com/read/31078196/premenstrual-dysphoric-disorder
#11
REVIEW
Teresa Lanza di Scalea, Teri Pearlstein
Premenstrual dysphoric disorder (PMDD) comprises emotional and physical symptoms and functional impairment that lie on the severe end of the continuum of premenstrual symptoms. Women with PMDD have a differential response to normal hormonal fluctuations. This susceptibility may involve the serotonin system, altered sensitivity of the GABAA receptor to the neurosteroid allopregnanalone, and altered brain circuitry involving emotional and cognitive functions. Serotonin reuptake inhibitors are considered the first-line treatment...
July 2019: Medical Clinics of North America
https://read.qxmd.com/read/31078195/neuroendocrine-networks-and-functionality
#12
REVIEW
Margaret Altemus
Women undergo developmental and cyclic changes in hormonal exposures that affect brain function and mental health. Some women are more vulnerable to the effects of these hormonal exposures, for reasons that remain to be determined. Evidence to date indicates that anxiety and mood disorders are the most sensitive to hormonal fluctuations in women but there is also growing evidence for a protective effect of female reproductive hormones on schizophrenia. The hormonal exposures of the menstrual cycle, pregnancy, the postpartum period, lactation, and menopause are quite different and may be associated with at least partially distinct symptom profiles...
July 2019: Medical Clinics of North America
https://read.qxmd.com/read/30955526/tom-brady-s-lungs
#13
EDITORIAL
Bimal H Ashar
No abstract text is available yet for this article.
May 2019: Medical Clinics of North America
https://read.qxmd.com/read/30955525/pulmonary-disease
#14
EDITORIAL
Ali I Musani
No abstract text is available yet for this article.
May 2019: Medical Clinics of North America
https://read.qxmd.com/read/30955524/preoperative-pulmonary-evaluation
#15
REVIEW
Angela Selzer, Mona Sarkiss
The preanesthesia evaluation is an opportunity to elucidate a patient's underlying medical disease, determine if the patient is optimized, treat modifiable conditions, screen for potentially unrecognized disorders, and present the clear picture of the patient's overall risk for perioperative complications. This article presents the preoperative assessment of pulmonary patients in 2 sections. First, the components of a thorough assessment of patients presenting for preanesthesia evaluation, which should occur for all patients, regardless of the presence of pulmonary pathology, are discussed...
May 2019: Medical Clinics of North America
https://read.qxmd.com/read/30955523/pulmonary-rehabilitation-in-the-management-of-chronic-lung-disease
#16
REVIEW
Sharon D Cornelison, Rodolfo M Pascual
Pulmonary rehabilitation is a core component of management of patients with chronic lung disease that have exercise or functional limitations. Causes of these limitations are manifold but include loss of skeletal muscle mass, power and endurance, diminished respiratory capacity owing to respiratory muscle weakness, inefficient gas exchange, and increased work of breathing, and impaired cardiovascular functioning. Besides physical limitations, patients with chronic lung disease have high rates of depression and anxiety leading to social isolation and increased health care use...
May 2019: Medical Clinics of North America
https://read.qxmd.com/read/30955522/pulmonary-function-testing-and-cardiopulmonary-exercise-testing-an-overview
#17
REVIEW
Katherine Krol, Mary Anne Morgan, Sandhya Khurana
Respiratory symptoms are common reasons for patients to seek care and contribute significantly to use of health care resources. Identifying the underlying etiology of a respiratory symptom is key to management; yet, pinpointing the cause can be a challenge. Familiarity with the tools available to help discern between the various contributing etiologies is crucial in guiding management. Assessment and quantification of pulmonary function can provide an objective measure to guide diagnosis and therapy. We review key points of pulmonary function evaluation, highlighting indications and contraindications, fundamentals of interpretation, and the limitations of each individual component...
May 2019: Medical Clinics of North America
https://read.qxmd.com/read/30955521/pulmonary-embolism
#18
REVIEW
Eno-Obong Essien, Parth Rali, Stephen C Mathai
Venous thromboembolism (VTE) includes pulmonary embolism (PE) and deep vein thrombosis. PE is the third most common cause of cardiovascular death worldwide after stroke and heart attack. Management of PE has evolved recently with the availability of local thrombolysis; mechanical extraction devices; hemodynamic support devices, like extracorporeal membrane oxygenation; and surgical embolectomy. There has been development of multidisciplinary PE response teams nationwide to optimize the care of patients with VTE...
May 2019: Medical Clinics of North America
https://read.qxmd.com/read/30955520/occupational-lung-disease
#19
REVIEW
David M Perlman, Lisa A Maier
Occupational exposures are a major cause of lung disease and disability worldwide. This article reviews the broad range of types of occupational lung diseases, including airways disease, pneumoconioses, and cancer. Common causes of occupational lung disease are reviewed with specific examples and clinical features. Emphasis on the importance of a detailed history to make an accurate diagnosis of an occupational lung disease is discussed.
May 2019: Medical Clinics of North America
https://read.qxmd.com/read/30955519/sarcoidosis
#20
REVIEW
Oscar Llanos, Nabeel Hamzeh
Sarcoidosis is a multisystemic granulomatous disease that affects individuals worldwide. The lungs are most commonly involved but any organ can be involved. It has variable manifestations and clinical course. Diagnosis of sarcoidosis is based on clinicopathologic findings and the exclusion of other causes of granulomatous disease. Its hallmark is the formation of granulomas in affected organs. Immunosuppressive therapy is the cornerstone of the management of sarcoidosis and is indicated when there is evidence of symptomatic or progressive disease or when critical organs (ocular, cardiac, nervous system) are involved...
May 2019: Medical Clinics of North America
journal
journal
25580
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"